降低RIP3的调节改善了心肌梗塞后的左心室机制和功能,通过调节NF-κB/NLRP3通路
Han Zhang1,2, Yuan Yin3, Shan Chen1
1Department of Stomatology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.
Open life sciences
|June 24, 2024
概括
降低RIPK3 (受体相互作用蛋白激酶3) 的调节,通过减少炎症和不良心脏重塑,改善心肌梗塞 (MI) 后的心脏功能. 这针对NLRP3炎症酶途径,为心力衰竭提供了潜在的治疗策略.
科学领域:
- 心血管生物学 心血管生物学
- 分子医学是分子医学.
- 炎症研究 炎症研究
背景情况:
- 不良的心脏重塑驱动心脏衰竭进展心肌梗塞 (MI) 后的心脏衰竭.
- 通过RIPK3介导的亡有助于心肌细胞损失和心脏功能障碍.
- 在NLRP3炎症中RIPK3的作用需要进一步的研究.
研究的目的:
- 研究RIPK3在MI后NLRP3炎症酶激活中的作用.
- 评估RIPK3敲击对心肌力学和心脏功能后MI的治疗潜力.
主要方法:
- 在小鼠中的心肌梗塞 (MI) 模型.
- 评估左心室 (LV) 心肌力学 (应变和应变率).
- 对RIPK3,NF-κB/NLRP3通路激活和炎症性细胞因子 (IL-1β,IL-18) 的分析.
- 评估心脏重塑后MI与RIPK3淘汰.
主要成果:
- 肌痛性心肌梗塞诱发了LV心肌力学损伤,特征是应变和应变速率降低.
- 在缺血和远程段中,RIPK3倒置显著改善了LV心肌力学.
- 抑制RIPK3抑制了NF-κB/NLRP3通路的激活,并降低了IL-1β和IL-18水平.
- 在MI之后,RIPK3抑制缓解了不良心脏重塑.
结论:
- RIPK3在NLRP3介导的炎症和不良心脏重塑中发挥着关键作用.
- 低调RIPK3可以改善心脏功能障碍,并改善心肌梗塞后的心肌力学.
- 准RIPK3为预防心肌炎症和心力衰竭中的心脏重塑提供了一个有前途的治疗策略.
相关概念视频
02:26NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
01:25Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...